BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1320562)

  • 1. Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer.
    Kohno N; Hamada H; Fujioka S; Hiwada K; Yamakido M; Akiyama M
    Chest; 1992 Jul; 102(1):117-22. PubMed ID: 1320562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of serum KL-6 antigen in a patient with radiation pneumonia.
    Hamada H; Kohno N; Akiyama M; Hiwada K
    Chest; 1992 Mar; 101(3):858-60. PubMed ID: 1541162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors.
    Hara R; Itami J; Komiyama T; Katoh D; Kondo T
    Chest; 2004 Jan; 125(1):340-4. PubMed ID: 14718465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum KL-6, a novel mucin-like glycoprotein, as an indicator of interstitial pneumonitis following lobectomy.
    Sakuma T; Takahashi K; Ohya N; Usuda K; Handa M
    Surg Today; 1999; 29(2):121-8. PubMed ID: 10030736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6.
    Kohno N; Kyoizumi S; Awaya Y; Fukuhara H; Yamakido M; Akiyama M
    Chest; 1989 Jul; 96(1):68-73. PubMed ID: 2661160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis.
    Goto K; Kodama T; Sekine I; Kakinuma R; Kubota K; Hojo F; Matsumoto T; Ohmatsu H; Ikeda H; Ando M; Nishiwaki Y
    Lung Cancer; 2001 Oct; 34(1):141-8. PubMed ID: 11557124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating KL-6 levels in patients with drug induced pneumonitis.
    Ohnishi H; Yokoyama A; Yasuhara Y; Watanabe A; Naka T; Hamada H; Abe M; Nishimura K; Higaki J; Ikezoe J; Kohno N
    Thorax; 2003 Oct; 58(10):872-5. PubMed ID: 14514942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin.
    Oyama T; Kohno N; Yokoyama A; Hirasawa Y; Hiwada K; Oyama H; Okuda Y; Takasugi K
    Lung; 1997; 175(6):379-85. PubMed ID: 9330247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
    Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
    Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity.
    Endoh Y; Hanai R; Uto K; Tanaka T; Ohta Y; Kasanuki H; Ohnishi S
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):2010-3. PubMed ID: 11139980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
    Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum KL-6 as a predictive marker of radiation pneumonitis in patients with breast-conservation therapy.
    Tokiya R; Hiratsuka J; Yoshida K; Imai S; Kajihara Y; Imajo Y
    Int J Clin Oncol; 2004 Dec; 9(6):498-502. PubMed ID: 15616881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis.
    Yokoyama A; Kohno N; Hamada H; Sakatani M; Ueda E; Kondo K; Hirasawa Y; Hiwada K
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1680-4. PubMed ID: 9817725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum KL-6 levels in pediatric patients: reference values for children and levels in pneumonia, asthma, and measles patients.
    Imai T; Takase M; Takeda S; Kougo T
    Pediatr Pulmonol; 2002 Feb; 33(2):135-41. PubMed ID: 11802251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
    Kohno N
    J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KL-6: a serum marker for interstitial pneumonia.
    Kobayashi J; Kitamura S
    Chest; 1995 Aug; 108(2):311-5. PubMed ID: 7634858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of Wilson-Mikity syndrome with high serum KL-6 levels.
    Takami T; Kumada A; Takei Y; Miyajima T; Hoshika A
    J Perinatol; 2003 Jan; 23(1):56-8. PubMed ID: 12556928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the serum KL-6 assay in patients with hepatitis C virus.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
    Intervirology; 2005; 48(6):400-4. PubMed ID: 16024944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis.
    Yanaba K; Hasegawa M; Hamaguchi Y; Fujimoto M; Takehara K; Sato S
    Clin Exp Rheumatol; 2003; 21(4):429-36. PubMed ID: 12942693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.